Edwards Lifesciences (EW) PT Raised at RBC Capital; 'A Catalyst Rich Year in 2026 and Beyond'
Tweet Send to a Friend
RBC Capital analyst Shagun Singh raised the price target on Edwards Lifesciences (NYSE: EW) to $100.00 (from $95.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
